EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 -0.1468
June 30, 2026 -0.1729
March 31, 2026 -0.1836
December 31, 2025 -0.1283
September 30, 2025 -0.1909
June 30, 2025 -0.2557
March 31, 2025 -0.2128
December 31, 2024 -0.26
September 30, 2024 -0.3309
June 30, 2024 -1.132
March 31, 2024 -0.7525
December 31, 2023 -0.6603
September 30, 2023 -0.5728
June 30, 2023 -0.6546
Date Value
March 31, 2023 -0.4938
December 31, 2022 -0.376
September 30, 2022 -0.7254
June 30, 2022 -0.69
March 31, 2022 -0.6003
December 31, 2021 -0.8179
September 30, 2021 -0.8125
June 30, 2021 -0.2332
March 31, 2021 -0.4955
December 31, 2020 -0.5238
September 30, 2020 -0.9601
June 30, 2020 -0.5064
March 31, 2020 -0.4275

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Agenus, Inc. 0.0183
Amgen, Inc. 7.077
Anika Therapeutics, Inc. -0.0232
BioCryst Pharmaceuticals, Inc. 0.1417
Imunon, Inc. -0.6412